Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer

Summary

This phase II trial studies how well radiation therapy, paclitaxel, and carboplatin work in treating patients with high-risk endometrial cancer. Radiation therapy uses high energy x rays to kill tumor cells. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing or by stopping them from spreading. Giving radiation therapy with chemotherapy may kill more tumor cells.

Timeline

Start

2009-01-16

Primary completion

2019-10-01

Completion

2019-10-01

Outcome

Outcome not reported

Stopped (Enrollment): “Due to slow accrual. Results from the PORTEC3 the study rendered the hypothesis no longer valid.”

Drugs

Indications